The case for immunomodulatory approaches in treating HSV encephalitis.
about
Intravenous immunoglobulin for the treatment of childhood encephalitisEstablishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007-June 2012.Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.Intravenous immunoglobulin for the treatment of childhood encephalitis.Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection.
P2860
The case for immunomodulatory approaches in treating HSV encephalitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The case for immunomodulatory approaches in treating HSV encephalitis.
@en
The case for immunomodulatory approaches in treating HSV encephalitis.
@nl
type
label
The case for immunomodulatory approaches in treating HSV encephalitis.
@en
The case for immunomodulatory approaches in treating HSV encephalitis.
@nl
prefLabel
The case for immunomodulatory approaches in treating HSV encephalitis.
@en
The case for immunomodulatory approaches in treating HSV encephalitis.
@nl
P2093
P2860
P356
P1433
P1476
The case for immunomodulatory approaches in treating HSV encephalitis.
@en
P2093
Chandran Ramakrishna
Edouard M Cantin
Harry Openshaw
P2860
P304
P356
10.2217/FVL.12.138
P577
2013-03-01T00:00:00Z